Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Non-cash Items (2021 - 2025)

Biofrontera has reported Non-cash Items over the past 5 years, most recently at $515408.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $515408.0 for Q4 2025, up 10208.16% from a year ago — trailing twelve months through Dec 2025 was $515408.0 (up 10208.16% YoY), and the annual figure for FY2025 was $515408.0, up 10208.16%.
  • Non-cash Items for Q4 2025 was $515408.0 at Biofrontera, roughly flat from $515894.0 in the prior quarter.
  • Over the last five years, Non-cash Items for BFRIW hit a ceiling of $251.5 million in Q1 2023 and a floor of $1000.0 in Q4 2022.
  • Median Non-cash Items over the past 5 years was $59324.0 (2024), compared with a mean of $17.5 million.
  • Biggest five-year swings in Non-cash Items: skyrocketed 2514860.0% in 2023 and later tumbled 99.99% in 2024.
  • Biofrontera's Non-cash Items stood at $1.7 million in 2021, then plummeted by 99.94% to $1000.0 in 2022, then surged by 2681.5% to $27815.0 in 2023, then crashed by 82.02% to $5000.0 in 2024, then skyrocketed by 10208.16% to $515408.0 in 2025.
  • The last three reported values for Non-cash Items were $515408.0 (Q4 2025), $515894.0 (Q3 2025), and $134057.0 (Q2 2025) per Business Quant data.